rs138132875
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP6_Very_StrongBS1
The NM_013296.5(GPSM2):c.1816-8A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000402 in 1,612,714 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_013296.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCC1 | NM_001377458.1 | c.*2854T>C | 3_prime_UTR_variant | 13/13 | ENST00000369969.7 | NP_001364387.1 | ||
GPSM2 | NM_013296.5 | c.1816-8A>G | splice_region_variant, intron_variant | ENST00000264126.9 | NP_037428.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCC1 | ENST00000369969 | c.*2854T>C | 3_prime_UTR_variant | 13/13 | 5 | NM_001377458.1 | ENSP00000358986.3 | |||
GPSM2 | ENST00000264126.9 | c.1816-8A>G | splice_region_variant, intron_variant | 1 | NM_013296.5 | ENSP00000264126.3 |
Frequencies
GnomAD3 genomes AF: 0.00221 AC: 336AN: 152202Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000558 AC: 139AN: 249246Hom.: 0 AF XY: 0.000459 AC XY: 62AN XY: 134966
GnomAD4 exome AF: 0.000213 AC: 311AN: 1460394Hom.: 0 Cov.: 29 AF XY: 0.000180 AC XY: 131AN XY: 726568
GnomAD4 genome AF: 0.00222 AC: 338AN: 152320Hom.: 1 Cov.: 32 AF XY: 0.00219 AC XY: 163AN XY: 74482
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 09, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 07, 2023 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 05, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 30, 2012 | 1816-8A>G in Intron 14 of GPSM2: This variant is not expected to have clinical s ignificance because it has been identified in 0.8% (29/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs138132875). - |
Chudley-McCullough syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 11, 2021 | - - |
GPSM2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 16, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at